07 Feb 2018 by admin in UncategorizedComments Syros Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
30 Jan 2018 by admin in UncategorizedComments resTORbio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
25 Jan 2018 by admin in UncategorizedComments ARMO BioSciences Announces Pricing of Initial Public Offering
16 Jan 2018 by admin in UncategorizedComments Centrexion Therapeutics Announces Fast Track Designation Granted by FDA to CNTX-4975 for Treatment of Knee Osteoarthritis Pain
03 Jan 2018 by admin in UncategorizedComments Crescendo Biologics announces Humabody® evaluation in CAR-T by Takeda
02 Jan 2018 by admin in UncategorizedComments Centrexion Therapeutics Raises $67 Million; Launching Phase 3 Program for CNTX-4975 in Knee Osteoarthritis Pain in 2018
30 Nov 2017 by admin in UncategorizedComments resTORbio Raises $40 Million to Advance Selective TORC1 Inhibitors for Aging-Related Diseases and Conditions
11 Nov 2017 by admin in UncategorizedComments How Quan Plans To Deploy Its Inaugural $150m Healthcare Fund
29 Aug 2017 by admin in UncategorizedComments ARMO BioSciences Raises $67 Million in a Series C-1 Financing
06 Jul 2017 by admin in UncategorizedComments Qiagen (Suzhou) Raised RMB175mn in a Series A Financing
